A clinical trial of a drug treating Alzheimer's was successful. What does that mean for patients?

Published October 5, 2022 at 12:52 PM CDT

Facebook
Twitter
LinkedIn
Email

Your browser doesn’t support HTML5 audio

A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images)

Here & Now‘s Scott Tong speaks with STAT’s biotech reporter Damian Garde about a promising study of a drug that could reduce the cognitive effects of Alzheimer’s disease.

This article was originally published on WBUR.org.